Cargando…
Recurrent COVID‐19 infection in a case of rituximab‐induced hypogammaglobulinaemia
Patients with immunodeficiency are at an increased risk of recurrent COVID‐19 infection. They may lack the natural immune response that usually confers long‐lasting immunity. Here, we present our experience managing one such patient, who had a COVID‐19 infection twice, 5 months apart. He had a posit...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652043/ https://www.ncbi.nlm.nih.gov/pubmed/34934508 http://dx.doi.org/10.1002/rcr2.891 |